BJDX — Bluejay Diagnostics Share News
0.000.00%
Last trade - 00:00Brief: Bluejay Diagnostics And Argonaut Manufacturing Services Announce Strategic Partnership
Bluejay Diagnostics Q1 net loss unchanged
Brief: Bluejay Diagnostics, Inc. Announces Completion Of 624 Patient Enrollments In Symon-Ii Pivotal Clinical Trial
Brief: Bluejay Diagnostics Provides Corporate Update And 2026 Strategic Outlook
Brief: Bluejay Diagnostics Successfully Enrolls 545 Patients In Symon™ Ii Study And Advances Manufacturing Readiness Into 2026
NASDAQ RESUMED AT 09:00 AM
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT HALT NEWS PENDING AT 07:50 PM
Brief: Bluejay Diagnostics Announces Completion of Commercial-Scale IL-6 Antibody Production
Brief: Bluejay Diagnostics Inc - Enters Into Securities Purchase Agreement On Oct 9 - SEC Filing
U.S. STOCKS ON THE MOVE-InterDigital, Scholar Rock, Live Nation
U.S. STOCKS ON THE MOVE-Whirlpool, IREN, Cidara
U.S. STOCKS ON THE MOVE-Novo Nordisk, Oracle, Delta Air Lines
Bluejay Diagnostics' doubles after expanding partnership for sepsis test
Brief: Bluejay Diagnostics Says Donald Chase Appointed Chairperson Of Bluejay Board
Brief: Bluejay Diagnostics Provides Mid-Year Business And Corporate Update
Brief: Bluejay Diagnostics Announces Entry Into Warrant Inducement Transaction For Approximately $3.7 Million In Gross Proceeds
Brief: Bluejay Diagnostics Announces Pricing Of $8.75 Mln Underwritten Public Offering
Brief: Bluejay Diagnostics Announces Reverse Stock Split